Qscreen Ai Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Sheldon Kales
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Scotia Plaza Toronto ON Canada M5H 3Y2
- IPO Date
- Jan 8, 2021
- CIK
- 0001868079
- Website
- predictmedix.com
- Similar Companies
- Business
- Predictmedix AI Inc. develops artificial intelligence-powered technologies for workplace health and safety and healthcare applications; it operates in two segments, Workplace Health and Safety, and Healthcare. The company offers SmartHealth AI Stations, noninvasive contactless screening solutions using multispectral cameras to detect infectious disease symptoms including COVID-19, impairment from alcohol or cannabis, extreme fatigue, and mental health indicators; impairment detection screening scanners; mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. It also provides infectious disease symptom screening to identify individuals requiring definitive tests and advances AI tools for clinical-trial optimization and consumer digital health. Predictmedix AI Inc. maintains a strategic alliance with Pacific Mechatronics Pvt. Ltd. to scale AI health screening in defense sectors and pursues partnerships across the US, Canada, and South Asia. The company, founded in 1987 and headquartered in Toronto, Canada, changed its name from Predictmedix Inc. to Predictmedix AI Inc. in July 2023; recent developments include a multi-vertical growth strategy announced in 2025 emphasizing clinical-trial optimization and consumer digital health, expansion into mobile diagnostics with a smartphone-based AI-driven diabetic screening platform targeting India, production initiation of 15 SmartHealth AI Stations for US market deployment, non-brokered private placements closing in multiple tranches totaling over $560,000 in 2025 with strong insider participation, and presentation at the 25th MK Investment Conference in Munich in October 2025.
QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones
QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S.
QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time
QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios
QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets
QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths
QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America
QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico
Qscreen AI Announces Strategic U.S. Engagement to Drive Innovation in Public Safety and Institutional Health
Predictmedix AI Rebrands as QScreen AI Inc., (QAI) Harnessing Quantum-AI Synergy for Health Screening
CSE Bulletin: Name and Symbol Change - Predictmedix AI Inc. (PMED)
Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships
Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare
Predictmedix AI Inc - 2025 Year End Corporate Update
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Predictmedix AI Announces Closing of $460,150 First Tranche
Predictmedix AI Announces Non-Brokered Private Placement
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader